Draper Asset Management LLC Takes $565,000 Position in LENSAR, Inc. (NASDAQ:LNSR)

Draper Asset Management LLC bought a new position in LENSAR, Inc. (NASDAQ:LNSR - Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 40,040 shares of the company's stock, valued at approximately $565,000. LENSAR makes up 0.4% of Draper Asset Management LLC's holdings, making the stock its 14th largest position. Draper Asset Management LLC owned 0.34% of LENSAR at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in LNSR. Geode Capital Management LLC raised its position in shares of LENSAR by 5.6% during the 4th quarter. Geode Capital Management LLC now owns 106,058 shares of the company's stock valued at $948,000 after buying an additional 5,627 shares in the last quarter. Atria Investments Inc raised its position in LENSAR by 28.2% during the fourth quarter. Atria Investments Inc now owns 26,055 shares of the company's stock valued at $233,000 after purchasing an additional 5,729 shares during the period. Brandes Investment Partners LP lifted its stake in shares of LENSAR by 10.4% in the 4th quarter. Brandes Investment Partners LP now owns 489,318 shares of the company's stock valued at $4,375,000 after purchasing an additional 45,920 shares during the last quarter. Renaissance Technologies LLC lifted its stake in shares of LENSAR by 13.3% in the 4th quarter. Renaissance Technologies LLC now owns 348,891 shares of the company's stock valued at $3,119,000 after purchasing an additional 40,946 shares during the last quarter. Finally, Huntleigh Advisors Inc. purchased a new position in shares of LENSAR in the 1st quarter worth approximately $1,069,000. 40.15% of the stock is owned by institutional investors.

LENSAR Trading Down 0.8%

LNSR stock opened at $13.11 on Friday. The stock has a market cap of $154.57 million, a PE ratio of -2.70 and a beta of 0.50. LENSAR, Inc. has a 12 month low of $3.50 and a 12 month high of $17.31. The company has a 50-day moving average price of $13.27 and a 200 day moving average price of $12.32.

LENSAR (NASDAQ:LNSR - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported ($2.32) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by ($2.16). The business had revenue of $11.53 million for the quarter, compared to analysts' expectations of $13.40 million. LENSAR had a negative net margin of 99.17% and a negative return on equity of 737.30%.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. BTIG Research lowered LENSAR from a "strong-buy" rating to a "hold" rating in a report on Monday, March 24th. Lake Street Capital reiterated a "hold" rating and set a $15.00 price objective (down previously from $16.00) on shares of LENSAR in a research report on Monday, March 24th.

About LENSAR

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.